Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Ankylosing spondylitis |
📓
The Association of Fecal Microbiota in Ankylosing Spondylitis Cases with C-Reactive Protein and Erythrocyte Sedimentation Rate. Mediators of inflammation (Mediators Inflamm ) Vol: 2020 Issue Pages: 8884324 Pub: 2020 Epub: 2020 Nov 7 Authors Liu G , Hao Y , Yang Q , Deng S , Html Article Publication |
| Ankylosing spondylitis |
📓
A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin. Arthritis research & therapy (Arthritis Res Ther ) Vol: 21 Issue 1 Pages: 248 Pub: 2019 Nov 27 Epub: 2019 Nov 27 Authors Klingberg E , Magnusson MK , Strid H , Deminger A , Ståhl A , Sundin J , Simrén M , Carlsten H , Öhman L , Forsblad-d`Elia H , Html Article Publication |
| Ankylosing spondylitis |
📓
Variations in gut microbial profiles in ankylosing spondylitis: disease phenotype-related dysbiosis. Annals of translational medicine (Ann Transl Med ) Vol: 7 Issue 20 Pages: 571 Pub: 2019 Oct Epub: Authors Chen Z , Qi J , Wei Q , Zheng X , Wu X , Li X , Liao Z , Lin Z , Gu J , Html Article Publication |
| Ankylosing spondylitis |
📓
Altered Bacterial-Fungal Interkingdom Networks in the Guts of Ankylosing Spondylitis Patients. mSystems (mSystems ) Vol: 4 Issue 2 Pages: Pub: 2019 Mar-Apr Epub: 2019 Mar 26 Authors Li M , Dai B , Tang Y , Lei L , Li N , Liu C , Ge T , Zhang L , Xu Y , Hu Y , Li P , Zhang Y , Yuan J , Li X , Html Article Publication |
| Ankylosing spondylitis |
📓
Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis. Genome biology (Genome Biol ) Vol: 18 Issue 1 Pages: 142 Pub: 2017 Jul 27 Epub: 2017 Jul 27 Authors Wen C , Zheng Z , Shao T , Liu L , Xie Z , Le Chatelier E , He Z , Zhong W , Fan Y , Zhang L , Li H , Wu C , Hu C , Xu Q , Zhou J , Cai S , Wang D , Huang Y , Breban M , Qin N , Ehrlich SD , Html Article Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
